being and becoming in the world
I have been receiving weekly invites to this International Congress [to my NHS e-mail address]. The latest invitation makes the statement that “it’s all you need!” The previous invitation was … Continue reading “RCPsych Congress . . . it’s all you need!”
I submitted a rapid response to the BMJ last September after viewing galleries of photographs of the British Association of Psychopharmacology (BAP) Summer Meeting of 2016. The BMJ did not … Continue reading Rising stars: British Association of Psychopharmacology
I have recently posted on the promotion of Lurasidone (Latuda) in the UK. This has raised concerns for me about transparency of conflicts of interest for some of the key … Continue reading “A robust learning environment for healthcare professionals”
The launch in the UK of Lurisidone began in August 2014. My previous post on Lurasidone (Latuda) which has now been marketed in the UK followed the financial interests of … Continue reading Lurasidone [Latuda]: vigorously marketed in the UK
In my last post I considered the level of transparency provided by the British Association for Psychopharmacology (BAP) in relation to its recently published Guidelines on prescribing for depressive disorders. … Continue reading Stephen Stahl: $3,581,159 in payments from Pharma
The above Evidence-based guidelines for treating depressive disorders with antidepressants have recently been published. The British Association for Psychopharmacology are an organisation highly regarded by my profession of psychiatry. 12% of their … Continue reading British Association for Psychopharmacology Guidelines (BAP)
I recently wrote to the Department of Psychiatry, Medical Sciences Division, University of Oxford asking where the declarations of interest for their staff could be accessed by the public. The … Continue reading Declarations by the Department of Psychiatry, Oxford University
This leter has been published in the current edition of The BMJ: Reading this letter my thoughts returned to a lecture given by Professor Allan Young at a Royal College … Continue reading “A huge number of ‘bipolars’ are missed”